Preview
New technology for diagnosis and staging of prostate cancer has been developed, and understanding of the disease has improved. Predicting its course and affecting its outcome remain difficult, however. Should aggressive screening programs for asymptomatic men be implemented? What new approaches to treatment are being tried? How should patients be monitored for recurrence? Dr Kemp examines these and other questions.